The major limitation to exercise performance in COPD is lower limb muscle dysfunction
The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.
Abstract
POINT-COUNTERPOINTThe major limitation to exercise performance in COPD is lower limb muscle dysfunctionRichard Debigaré, and François MaltaisRichard Debigaré, and François MaltaisPublished Online:01 Aug 2008https://doi.org/10.1152/japplphysiol.90336.2008aMoreSectionsPDF (152 KB)Download PDF ToolsExport citationAdd to favoritesGet permissionsTrack citations Exercise intolerance is ubiquitous in patients suffering from chronic obstructive pulmonary disease (COPD). Functional impairment can be evidenced by a lower walking capacity and cycling endurance compared with age-matched healthy controls (26). Reduced functional status and low level of daily physical activity predict poor quality of life (24), high health care use (7), and mortality (9) in these patients. A comprehensive understanding of the mechanisms of exercise intolerance is therefore of utmost importance to impact on these adverse outcomes and modify the evolution of the functional impairment associated with COPD.Respiratory impairment is not sufficient in itself to explain exercise intolerance in COPD. The weak correlation between FEV1 or inspiratory capacity and exercise tolerance implies that other factors must be involved (21, 14). In 1992, Killian and collaborators (15) published a landmark paper that draws attention to the impact of the lower limb muscles on exercise intolerance in COPD. They reported that leg discomfort was a frequent exercise-limiting symptom invoked by these patients after a standardized cycling protocol. This report was the foundation of the rationale used by scientists to investigate lower limb muscle dysfunction in COPD. At that time, no one could have predicted how vast this research area would develop.Although the ventilatory system is clearly dysfunctional in COPD, we will demonstrate that peripheral limitation to exercise tolerance is frequent in patients with COPD. To persuade the reader, morphological, biochemical, and clinical evidences demonstrating causal relationship between lower limb muscle dysfunction and exercise limitation will be exposed. We will focus on the tolerance to submaximal exercises, which are particularly influenced by the function and aerobic capacity of the lower limb muscles (3).Morphological and biochemical evidences of lower limb muscle dysfunction in COPD.The prevalence of lower limb muscle atrophy in COPD ranges from 21 to 45% depending on the population being investigated and its operational definition (23, 27). Unexpectedly, muscle atrophy can even be present in patients with normal body weight (27). Given that muscle strength is mostly determined by muscle mass, muscle weakness is therefore highly prevalent in COPD (4, 11). Patients with COPD also have a poor resistance to isolated leg exercises and increased susceptibility to muscle fatigue (16), two correlates of impaired exercise capacity (1). In parallel, altered muscle energy metabolism as assessed by 31phosphorus magnetic resonance spectroscopy (30) has also been correlated to reduced exercise capacity in patients with COPD (30).Muscle atrophy and impaired energy production are accountable for muscle weakness and increased susceptibility to fatigue, two strong determinants of exercise capacity (13). The physiological link between weakness, leg fatigue, and exercise intolerance was elegantly illustrated by Hamilton and colleagues (12). They evaluated the relationship between the perception of leg fatigue, work capacity, and muscle strength in normal individuals and patients with lung diseases, most of whom had COPD. Three interrelated observations, valid in healthy individuals and patients with lung diseases, were made 1) for a given power output, the perception of leg fatigue was greater in weaker compared with stronger individuals, 2) peak exercise capacity was reduced in weak individuals, and 3) the strength of the quadriceps was a key determinant of exercise capacity, independent of the impairment in lung function.Convincing biochemical data also support the thesis that lower limb muscle dysfunction is a major contributor to exercise intolerance in COPD. At the cellular level, several morphological and structural modifications have been observed in the quadriceps of patients with moderate to severe COPD (2). These changes substantially compromise the metabolic performance and work output of activated muscles during exercise. Specifically, the morphological changes observed include reduction in type I fiber proportion (28) as well as reduction in cross-sectional area (CSA) for type I and II fibers (10, 28) that is proportional to the reported reduction in mid-thigh cross-sectional area (4). This former observation suggests that contractile protein deficit is largely responsible for both muscle atrophy and weakness and thus contribute to impaired exercise capacity.The muscle structural and energetic changes described in COPD involve a reduction in myosin heavy chain I proportion (19) and a decrease in oxidative enzyme activiti
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Adaptations of skeletal muscle to endurance exercise and their metabolic consequences
Holloszy, J. O., & Coyle, E. F. (1984) · Journal of Applied Physiology · doi:10.1152/jappl.1984.56.4.831 · Cited by 1,985
American Thoracic Society/European Respiratory Society statement on pulmonary rehabilitation
Nici, L., Donner, C., Wouters, E., Zuwallack, R., Ambrosino, N., Bourbeau, J., Carone, M., Celli, B., Engelen, M., Fahy, B., et al. (2006) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200508-1211st · Cited by 1,966
Self-citationGarcia-Aymerich, J., Lange, P., Benet, M., Schnohr, P., & Anto, J. M. (2006) · Thorax · doi:10.1136/thx.2006.060145 · Cited by 1,113
Peripheral Muscle Weakness in Patients with Chronic Obstructive Pulmonary Disease
BERNARD, S., LeBLANC, P., WHITTOM, F., CARRIER, G., JOBIN, J., BELLEAU, R., & MALTAIS, F. (1998) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.158.2.9711023 · Cited by 817
Self-citationO'DONNELL, D. E., LAM, M., & WEBB, K. A. (1999) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.160.2.9901038 · Cited by 485 · cited 1×
“The weak correlation between FEV1 or inspiratory capacity and exercise tolerance implies that other factors must be involved (21, 14).”
BackgroundWHITTOM, F., JOBIN, J., SIMARD, P.-M., LEBLANC, P., SIMARD, C., BERNARD, S., BELLEAU, R., & MALTAIS, F. (1998) · Medicine & Science in Sports & Exercise · doi:10.1097/00005768-199810000-00001 · Cited by 447
Self-citation
Cited by
Spruit, M. A., Singh, S. J., Garvey, C., ZuWallack, R., Nici, L., Rochester, C., Hill, K., Holland, A. E., Lareau, S. C., Man, W. D.-C., et al. (2013) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201309-1634st · Cited by 3,938
Self-citationPathogenesis of hyperinflation in chronic obstructive pulmonary disease
Saey, Gagnon, P., Guenette, J., Langer, D., Laviolette, L., Mainguy, V., Maltais, F., & Ribeiro, F. (2014) · International Journal of Chronic Obstructive Pulmonary Disease · doi:10.2147/copd.s38934 · Cited by 204
“13,14 While exercise intolerance in patients with COPD is complex and multifactorial, 15–17 dynamic hyperinflation remains a major contributor to exercise limitation that is consistently observed in this disease.”
Self-citationImpact of pulmonary system limitations on locomotor muscle fatigue in patients with COPD
Amann, M., Regan, M. S., Kobitary, M., Eldridge, M. W., Boutellier, U., Pegelow, D. F., & Dempsey, J. A. (2010) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00183.2010 · Cited by 150
Chiappa, G. R., Queiroga, F., Meda, E., Ferreira, L. F., Diefenthaeler, F., Nunes, M., Vaz, M. A., Machado, M. C. L., Nery, L. E., & Neder, J. A. (2009) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200811-1793oc · Cited by 122
“The main novel findings of the present study are that heliox (1) speeded the on-exercise kinetics of _ Q, HR, SV, and pulmonary _ VO2; (2) slowed the dynamics of [HHb], a noninvasive index of fractional O2 extraction; and (3) decreased [HHb], muscle fiber recruitment, and leg effort scores during the steady-state phas…”
BackgroundFactors Limiting Exercise Tolerance in Chronic Lung Diseases
Vogiatzis, I., & Zakynthinos, S. (2012) · Comprehensive Physiology · doi:10.1002/cphy.c110015 · Cited by 77
“…limited blood/oxygen supply individuals be reduced O 2 utilization capacity at the level of the peripheral (emphysema and/or chronic bronchitis) and various comorbidities (122), the prevailing determinants of impaired exercise capacity in patients with COPD may vary among patients (16, 67, 232).”
Metadata
- Authors
- Debigaré, R., & Maltais, F.
- Venue
- Journal of Applied Physiology
- Publisher
- American Physiological Society
- Published
- 2008-08
- Volume
- 105
- Issue
- 2
- Pages
- 751-753
- ISSN
- 0161-7567 (ISSN-L)
- 8750-7587
- 1522-1601
- OpenAlex
- W1982449717
- Cited by
- 118
- References
- 6
- FWCI
- 6.68
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.